Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3228 |  IMRX Immuneering Corporation - Class A Common Stock | 5.23 USD | -1.32% | +1.36% | +19.41% | +8.96% | 338.37 M USD | ||
| 3239 |  STRO Sutro Biopharma, Inc. - Common Stock | 20.25 USD | -3.75% | -2.69% | -11.88% | +16.45% | 335.77 M USD | ||
| 3240 |  YDES YD Bio Limited - Ordinary Shares | 4.74 USD | +1.07% | +49.06% | +114.48% | -40.75% | 335.54 M USD | ||
| 3254 |  OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 5.46 USD | +1.87% | +18.70% | +43.68% | +114.12% | 328.17 M USD | ||
| 3275 |  IRD Opus Genetics, Inc. - Common Stock | 4.09 USD | +0.99% | +10.84% | +32.79% | +9.95% | 340.27 M USD | ||
| 3286 |  VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.30 USD | +0.38% | -0.38% | +2.32% | -4.16% | 320.45 M USD | ||
| 3332 |  NMRA Neumora Therapeutics, Inc. - Common Stock | 1.61 USD | -1.23% | +9.52% | +6.62% | -0.62% | 302.51 M USD | ||
| 3348 |  AVXL Anavex Life Sciences Corp. - Common Stock | 3.19 USD | -1.54% | -0.62% | +32.37% | -66.46% | 295.62 M USD | ||
| 3357 |  ACIU AC Immune SA - Common Stock | 2.89 USD | -0.34% | +13.78% | +29.02% | +35.68% | 294.04 M USD | ||
| 3359 |  RNAC Cartesian Therapeutics, Inc. - Common Stock | 10.15 USD | +1.10% | +6.95% | +27.03% | +10.81% | 307.09 M USD | ||
| 3364 |  FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.82 USD | -0.26% | +0.79% | +1.60% | -44.48% | 291.46 M USD | ||
| 3382 |  FATE Fate Therapeutics, Inc. - Common Stock | 2.36 USD | +1.29% | -9.23% | -5.22% | +101.71% | 282.78 M USD | ||
| 3401 |  SRZN Surrozen, Inc. - Common Stock | 23.59 USD | -1.67% | -3.28% | +15.98% | +105.31% | 277.27 M USD | ||
| 3402 |  TRDA Entrada Therapeutics, Inc. - Common Stock | 7.28 USD | -3.83% | -1.62% | +22.35% | +4.45% | 283.46 M USD | ||
| 3403 |  TTRX Turn Therapeutics Inc. - Common Stock | 9.32 USD | -1.48% | -6.80% | +8.50% | -6.80% | 277.62 M USD | ||
| 3407 |  ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 3.84 USD | +0.26% | +4.63% | -11.93% | +93.94% | 275.22 M USD | ||
| 3414 |  ALXO ALX Oncology Holdings Inc. - Common Stock | 1.99 USD | -2.45% | +1.02% | -1.97% | +63.11% | 275.17 M USD | ||
| 3420 |  LCTX Lineage Cell Therapeutics, Inc. Common Stock | 1.10 USD | +0.92% | +1.85% | +4.76% | -36.05% | 278.20 M USD | ||
| 3422 |  ELDN Eledon Pharmaceuticals, Inc. - Common Stock | 3.35 USD | -2.90% | -8.72% | -8.97% | +26.89% | 272.22 M USD | ||
| 3424 |  IVVD Invivyd, Inc. - Common Stock | 0.92 USD | -8.00% | +26.03% | +50.82% | +73.58% | 271.18 M USD |
Noticias Biotechnology Stocks
Las acciones de Alto Neuroscience alcanzan máximos históricos a 35,42 dólares
Deutsche Bank rebaja argenx a Mantener por valoración
¿Por qué cae hoy la acción de Monte Rosa Therapeutics?
Las acciones de Biomea Fusion se disparan tras completar el ensayo sobre diabetes
Las acciones de Monte Rosa caen al inicio de un estudio de fase 2 contra el cáncer de próstata
Las acciones de Crinetics Pharmaceuticals alcanzan máximos históricos en 84,8 dólares
H.C. Wainwright reitera su calificación de Biomea Fusion tras inscripción en ensayo
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.08 | +642.86% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0026 | +160.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.65 | +20.44% |
 APRE Aprea Therapeutics, Inc. - Common Stock | 0.75 | +17.19% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.81 | +16.77% |
 BCTXZ BriaCell Therapeutics Corp. - Warrant | 0.1201 | +14.38% |
 CRDF Cardiff Oncology, Inc. - Common Stock | 1.00 | +13.64% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0045 | -50.00% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 7.84 | -26.87% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.09 | -18.17% |
 ADXN Addex Therapeutics Ltd - American Depositary Shares | 4.14 | -16.19% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.0928 | -15.48% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTXL BriaCell Therapeutics Corp. - Warrants | 0.9500 | -12.04% |